2026 Dmitry I. Gabrilovich: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	119	334	307	28	28	342	91587
Medicine	119	3803	3561	373	358	342	91587

Dmitry I. Gabrilovich publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Dmitry I. Gabrilovich sits on this spectrum.

62 publications 807+

This scientist: 342 publications — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Dmitry I. Gabrilovich D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Dmitry I. Gabrilovich sits on this spectrum.

40 D-Index 157+

This scientist: 119 D-Index — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Dmitry I. Gabrilovich is affiliated with AstraZeneca in the United Kingdom. Their research spans multiple disciplines, primarily focusing on immunology, microbiology, medicine, and biochemistry, genetics, and molecular biology. The scientist has contributed extensively to fields such as immunology, molecular biology, oncology, pulmonary and respiratory medicine, and cancer research.

The core topics of their work involve immune cells in cancer, cancer immunotherapy and biomarkers, immune response and inflammation, ferroptosis and cancer prognosis, neutrophil, myeloperoxidase and oxidative mechanisms, phagocytosis and immune regulation, and immune cell function and interaction.

Key publications of Dmitry I. Gabrilovich include:

Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity, 2021, Nature Reviews Immunology
Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death, 2020, Nature Chemical Biology
Ferroptosis of tumour neutrophils causes immune suppression in cancer, 2022, Nature
Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice, 2021, The Journal of Experimental Medicine
Therapeutic targeting of tumour myeloid cells, 2023, Nature Reviews Cancer

Frequent co-authors with whom Dmitry I. Gabrilovich has collaborated include:

Emilio Sanseviero
Andrew V. Kossenkov
Yulia Nefedova
Serge Y. Fuchs
Valerian E. Kagan

The scientist's work is frequently published in several prominent scientific venues. These include:

Cancer Research
Cancer Immunology Research
Nature Communications
Cancer Discovery
Cancer Cell

Best Publications

Myeloid-derived suppressor cells as regulators of the immune system.

Dmitry I. Gabrilovich;Srinivas Nagaraj

7873
Citations
Understanding the tumor immune microenvironment (TIME) for effective therapy.

Mikhail Binnewies;Edward W. Roberts;Kelly Kersten;Vincent Chan

5622
Citations
Coordinated regulation of myeloid cells by tumours

Dmitry I. Gabrilovich;Suzanne Ostrand-Rosenberg;Vincenzo Bronte

4028
Citations
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells.

Dmitry I. Gabrilovich;Dmitry I. Gabrilovich;Hailei L. Chen;Khaled R. Girgis;H. Thomas Cunningham

2840
Citations
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

Vincenzo Bronte;Sven Brandau;Shu Hsia Chen;Mario P. Colombo

2813
Citations
Immunosuppressive Strategies that are Mediated by Tumor Cells

Gabriel Adrián Rabinovich;Dmitry Gabrilovich;Eduardo Sotomayor

2104
Citations
Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice

Je-In Youn;Srinivas Nagaraj;Michelle Collazo;Dmitry I. Gabrilovich

2081
Citations
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.

Vinit Kumar;Sima Patel;Evgenii Tcyganov;Dmitry I. Gabrilovich

2029
Citations
Myeloid-Derived Suppressor Cells

Dmitry I. Gabrilovich

1853
Citations
Myeloid-derived suppressor cells coming of age.

Filippo Veglia;Michela Perego;Dmitry Gabrilovich

1794
Citations
Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer.

Bond Almand;Joseph I. Clark;Ekaterina Nikitina;James van Beynen

1743
Citations
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity.

Filippo Veglia;Emilio Sanseviero;Dmitry I. Gabrilovich

1636
Citations
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells.

Tianhong Wang;Guilian Niu;Marcin Kortylewski;Lyudmila Burdelya

1474
Citations
Altered recognition of antigen is a mechanism of CD8 + T cell tolerance in cancer

Srinivas Nagaraj;Kapil Gupta;Vladimir Pisarev;Leo Kinarsky

1418
Citations
Vascular Endothelial Growth Factor Inhibits the Development of Dendritic Cells and Dramatically Affects the Differentiation of Multiple Hematopoietic Lineages In Vivo

Dmitry Gabrilovich;Tadao Ishida;Tsunehiro Oyama;Sophia Ran

1389
Citations
Mechanisms and functional significance of tumour-induced dendritic-cell defects.

Dmitry I. Gabrilovich

1374
Citations
History of myeloid-derived suppressor cells

James E. Talmadge;Dmitry I. Gabrilovich

1336
Citations
HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment

Cesar A. Corzo;Thomas Condamine;Lily Lu;Matthew J. Cotter

1314
Citations
Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function

Thomas Condamine;Dmitry I. Gabrilovich

1142
Citations
Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein

Pingyan Cheng;Cesar A. Corzo;Noreen Luetteke;Bin Yu

1092
Citations
The Nature of Myeloid-Derived Suppressor Cells in the Tumor

Microenvironment Kumar;Sima Patel;Evgenii Tcyganov;Dmitry I. Gabrilovich

1
Citations

Frequent Co-Authors

Scott J. Antonia Duke University

David P. Carbone The Ohio State University

Valerian E. Kagan University of Pittsburgh

Lucia R. Languino Thomas Jefferson University

Vladimir A. Tyurin University of Pittsburgh

Andrew V. Kossenkov The Wistar Institute

Dario C. Altieri The Wistar Institute

Stella C. Knight Imperial College London

David W. Speicher The Wistar Institute

Sunil Chada The University of Texas MD Anderson Cancer Center

External Links

Personal website of Dmitry I. Gabrilovich

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Many professionals pursue advanced nursing roles to complement their immunology expertise. For example, understanding how much do dnp nurses make can help you evaluate the financial benefits of pursuing a Doctor of Nursing Practice (DNP) degree.

If your goal is to shift focus within nursing specialties, specialized programs such as acnp programs provide a pathway from Family Nurse Practitioner (FNP) roles to Acute Care Nurse Practitioner positions, which often intersect with immunology-related patient care.

Additionally, accelerated educational options like the accelerated fnp program offer a faster route for licensed nurses to become certified Family Nurse Practitioners, supporting quicker career advancement in immunology-focused healthcare settings.

For those new to nursing, exploring quality online rn programs for non nurses can provide foundational skills and open doors to nursing roles critical in immunology research and patient treatment.